These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38375190)

  • 1. The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease.
    Zhang Y; Xiang L; Qi F; Cao Y; Zhang W; Lv T; Zhou X
    Front Endocrinol (Lausanne); 2024; 15():1322563. PubMed ID: 38375190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic profiles and body composition of lean metabolic associated fatty liver disease.
    Cheng YM; Kao JH; Wang CC
    Hepatol Int; 2021 Apr; 15(2):405-412. PubMed ID: 33539004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study.
    Liu Z; He H; Dai Y; Yang L; Liao S; An Z; Li S
    Lipids Health Dis; 2022 Jun; 21(1):55. PubMed ID: 35752830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment and Analysis of Risk Prediction Model for Metabolic Dysfunction-Associated Fatty Liver Disease in Physical Examination Population].
    Xia B; He H; Qin K; Li SQ; An ZM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):591-595. PubMed ID: 37248589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of clinical and pathological features of chronic hepatitis B combined with metabolic-associated fatty liver disease].
    Shang MY; Chen YZ; Bao J; Tong YL
    Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):126-132. PubMed ID: 37137826
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study.
    Cui J; Liu Y; Li M; Yin J; Yang J; Xu L
    BMC Endocr Disord; 2024 Mar; 24(1):27. PubMed ID: 38438865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific Increase in Small Dense Low-Density Lipoprotein-Cholesterol Levels beyond Triglycerides in Patients with Diabetes: Implications for Cardiovascular Risk of MAFLD.
    Hirano T; Satoh N; Ito Y
    J Atheroscler Thromb; 2024 Jan; 31(1):36-47. PubMed ID: 37438123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population.
    Moriyama K; Inoue N; Imai J; Masuda Y; Yamada C; Kishimoto N; Takashimizu S; Kubo A; Nishizaki Y
    Metab Syndr Relat Disord; 2023 Nov; 21(9):489-496. PubMed ID: 37878804
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of concomitant hepatitis C virus infection on liver and cardiovascular risks in patients with metabolic-associated fatty liver disease.
    Tsai PS; Cheng YM; Wang CC; Kao JH
    Eur J Gastroenterol Hepatol; 2023 Nov; 35(11):1278-1283. PubMed ID: 37773778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of TG/HDL-C Combined with Liver Function Indexes to Predict Metabolic-Associated Fatty Liver Disease].
    Xia JX; Zhao YH; He H; Liang SS; Gan W; Li GX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):764-769. PubMed ID: 36224676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.
    Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
    BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum isthmin-1 is a potential biomarker for metabolic dysfunction associated fatty liver disease in patients with metabolic syndrome and type 2 diabetes mellitus.
    Lei X; Chen H; Xu Y; Yang Z; Zhang L; Wang C; Du H
    BMJ Open Diabetes Res Care; 2024 Sep; 12(5):. PubMed ID: 39322582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents.
    Schusterova I; Leenen FH; Jurko A; Sabol F; Takacova J
    Pediatr Obes; 2014 Feb; 9(1):63-70. PubMed ID: 23504985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease.
    Wu T; Ye J; Shao C; Li F; Lin Y; Ma Q; Wang W; Feng S; Zhong B
    Front Endocrinol (Lausanne); 2021; 12():691556. PubMed ID: 34899591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of clinical characteristics and risk factors of hepatic fibrosis in children with chronic hepatitis B combined with metabolic-related fatty liver disease].
    Li W; Jiang LN; Zhao BK; Liu HY; Zhao JM
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):601-607. PubMed ID: 37400384
    [No Abstract]   [Full Text] [Related]  

  • 19. Usefulness of Body Fat and Visceral Fat Determined by Bioimpedanciometry versus Body Mass Index and Waist Circumference in Predicting Elevated Values of Different Risk Scales for Non-Alcoholic Fatty Liver Disease.
    Gordito Soler M; López-González ÁA; Vallejos D; Martínez-Almoyna Rifá E; Vicente-Herrero MT; Ramírez-Manent JI
    Nutrients; 2024 Jul; 16(13):. PubMed ID: 38999907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.